IL-17F

IL-17F Overview

English NameInterleukin-17FApproved Drugs0
Drugs in Clinical Trials5Target SynonymCytokine ML-1,Interleukin-17F,IL17F,Interleukin 17F,IL-17F,CANDF6,ML-1,ML1
Highest Development StageNDA/BLA
English NameInterleukin-17F
Target SynonymCytokine ML-1,Interleukin-17F,IL17F,Interleukin 17F,IL-17F,CANDF6,ML-1,ML1
Approved Drugs0
Drugs in Clinical Trials5
Highest Development StageNDA/BLA

IL-17F Product List

  • Product Category

    Protein (7)

  • Product Status

    Launched (7)

  • Species

    Human (3)Mouse (2)Cynomolgus (2)

  • Tag

    His Tag (4)His Tag & Avi Tag (3)

  • Conjugate

    Unconjugated (4)Biotin-labeled (3)

IL-17F Background

Interleukin-17F (IL17F) is also known as Interleukin-24 (IL24), Cytokine ML-1, is a secreted disulfide-linked homodimer which belongs to the IL-17 family. There are at least six members of the IL-17 family in humans and in mice: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (also called IL-25) and IL-17F (also called IL-24). IL-17 represents a family of structurally related cytokines that share a highly conserved C-terminal region but differ from one another in their N-terminal regions and in their distinct biological roles. IL-17F / IL-24 is expressed in activated, but not resting, CD4+ T-cells and activated monocytes. IL17F / Interleukin-24 stimulates the production of other cytokines such as IL-6, IL-8 and granulocyte colony-stimulating factor, and can regulate cartilage matrix turnover. IL17F / IL-24 stimulates PBMC and T-cell proliferation and Inhibits angiogenesis. Defects in IL17F are the cause of familial candidiasis type 6 (CANDF6).

IL-17F Synonyms

IL-17F,Interleukin-17F,Cytokine ML-1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SonelokimabALX-0761; MSB-0010841; M-1095Phase 3 ClinicalAblynx NvArthritis, Psoriatic; Hidradenitis Suppurativa; Psoriasis
Details
DMT-310DMT-310Phase 3 ClinicalDermataAcne Vulgaris; Rosacea
Details
ORKA-002ORKA-002; PR-029; ORKA-021Phase 2 ClinicalParagon Therapeutics IncArthritis, Psoriatic; Plaque psoriasis; Psoriasis
Details
PN-881PN-881Phase 1 ClinicalProtagonist Therapeutics IncDermatitis; Psoriasis
Details
HY-1770HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770Phase 1 ClinicalSuzhou Pharmavan Co LtdDermatitis, Atopic; Plaque psoriasis
Details
  • Overview
  • Product List
  • Clinical Drug Information